| 000 | 01599 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514184745.0 | ||
| 264 | 0 | _c20040907 | |
| 008 | 200409s 0 0 eng d | ||
| 022 | _a0926-9959 | ||
| 024 | 7 |
_a10.1111/j.1468-3083.2004.00827.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAlbanese, G | |
| 245 | 0 | 0 |
_aThe effects of orally administered terbinafine on sebum composition. _h[electronic resource] |
| 260 |
_bJournal of the European Academy of Dermatology and Venereology : JEADV _cMay 2004 |
||
| 300 |
_a392-3 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Letter | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntifungal Agents _xadministration & dosage |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aDermatomycoses _xdiagnosis |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNaphthalenes _xadministration & dosage |
| 650 | 0 | 4 | _aProbability |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 |
_aSebum _xdrug effects |
| 650 | 0 | 4 | _aTerbinafine |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMarca, S | |
| 700 | 1 | _aCamera, E | |
| 700 | 1 | _aPicardo, M | |
| 773 | 0 |
_tJournal of the European Academy of Dermatology and Venereology : JEADV _gvol. 18 _gno. 3 _gp. 392-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1468-3083.2004.00827.x _zAvailable from publisher's website |
| 999 |
_c14808814 _d14808814 |
||